PD-L1, expressed in the majority of tumor cells, is the ligand of PD-1 expressed in immune cells, and the activation of PD-1/PD-L1 results in the blockage of T-cell activation, thereby aiding tumor cells in evading immune surveillance [26,27]. This evidence concerns the gene CD274 and neoplasm.